Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A clinical study of MK-2870 in people with stomach cancer (MK-2870-015) Ended

2023-505423-31-00 advanced or metastatic gastric adenocarcinoma, gastroes 5 2024-08-08
Phase I/II study of ANV600 single agent or in combination with pembrolizumab in participants with advanced solid tumors (EXPAND-1) Ended

2023-509633-39-00 Advanced solid tumours 7 2024-08-06
A Phase I study of STA551 and STA551 in combination with atezolizumab in patients with solid tumours Ended

2023-508764-30-00 Locally advanced or metastatic solid tumors 1 2024-07-31
Phase 2 Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma Ended

2023-505177-32-00 Intermediate-high -risk RCC, high-risk RCC who have und 4 2024-07-31
Comparison of targeted radiotherapy with and without short-term hormonal treatment (6 months) Ended

2024-511252-41-00 Patients with biochemical recurrence after primary trea 5 2024-07-30
A Phase I, open-label, multi-center exploratory safety and efficacy study with PSMA, SSTR2 and GRPR targeted radioligand therapy in metastat… Ended

2023-505655-43-00 Metastatic neuroendocrine prostate cancer 7 2024-07-29
A Phase 1, First-in-Human, Dose Escalation Study of JNJ-88998377 in Participants with Relapsed/Refractory B-cell NHL Ended

2023-509258-71-00 relapsed or refractory B‑cell non-Hodgkin lymphomas 1 2024-07-24
Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736). An open label randomized phase II trial with durvalumab following Stereotacti… Ended

2024-512439-54-01 Non-small cell lung cancer (NSCLC) 4 2024-07-24
Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to expre… Ended

2024-515467-66-00 Acute lymphoblastic leukemia 4 2024-07-22
Single arm phase II study of ctDNA-guided encorafenib plus cetuximab retreatment in patients with BRAF V600E mutated mCRC. BRICKET study Ended

2023-509088-26-00 Metastatic colorectal cancer 4 2024-07-22
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplas… Ended

2023-509947-29-00 Anemia in patients with very low, low or intermediate r 4 2024-07-18
A Clinical Study to Evaluate the Safety and Efficacy of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small … Ended

2023-508256-19-00 Unresectable Metastatic Non-small Cell Lung Cancer 9 2024-07-15
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell… Ended

2023-503594-38-00 Select B-Cell malignancies. 1 2024-07-15
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary origin Ended

2023-505592-69-00 Carcinoma of Unknown Primary 5 2024-07-12
AN INTERVENTIONAL SAFETY AND EFFICACY PHASE 1B/2, OPEN-LABEL STUDY TO INVESTIGATE TOLERABILITY, PK, AND ANTITUMOR ACTIVITY OF VEPDEGESTRANT … Ended

2023-508130-33-00 ADVANCED OR METASTATIC BREAST CANCER 9 2024-07-03
Add-Aspirin: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and surv… Ended

2024-511306-23-00 Breast cancer, colon cancer, rectal cancer, stomach can 5 2024-07-01
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Ended

2023-506228-10-00 Pancreatic Ductal Adenocarcinoma 7 2024-06-27
A phase II, randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) w… Ended

2024-512023-37-00 Prostate cancer 4 2024-06-27
A study to learn the effects of ripretinib (study drug) on how midazolam behaves in the body of people with advanced gastrointestinal stroma… Ended

2022-501477-40-00 Advanced Gastrointestinal Stromal Tumor 3 2024-06-25
TGF‐β And PDL‐1 inhibition with Bintrafusp alfa in Esophageal Squamous Cell carcinoma combined with chemoradiation TheRapY (TAPESTRY) Ended

2023-503312-32-00 Esophageal squamous cell carcinoma 4 2024-06-24
Breast cancer prevention in women at increased risk using low dose tamoxifen and/or diet and life style changes: a randomized 4 arms clinica… Ended

2023-503994-39-00 Healthy women aged 18-70 either carriers of a germline 4 2024-06-21
A Phase 3 study of Etentamig vs Standard Available Therapies in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) (3L+ RRMM Monot… Ended

2023-506668-15-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2024-06-17
Multicentric phase II trial to evaluate the efficacy and safety of Ibrutinib in combination with rituximab in patients with indolent clinica… Ended

2024-512370-94-00 Mantle Cell Lymphoma 4 2024-06-13
Phase 1 First in Human Study to Explore AMG 355 as Monotherapy and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Ended

2023-509047-26-00 Dose Escalation: Non-small cell lung cancer (NSCLC), co 1 2024-06-13